APCER Life Sciences
Melissa Foley serves as the Executive Director and Head of Business Development and Growth Strategist at APCER Life Sciences since April 2024, specializing in Pharmacovigilance, Risk Management, Medical Information, Regulatory, Quality Assurance, and Medical Writing. Prior to this role, Melissa held the position of Executive Director of Business Development at UBC from September 2020 to April 2024, focusing on relationship and revenue growth. From September 2018 to August 2020, Melissa was the Senior Enterprise Client Relationship Director at Parexel International, overseeing strategic partner account responsibilities. Prior roles include Senior Executive Director of Business Development at PAREXEL from January 2016 to September 2018, concentrating on growth within larger biotech accounts, and Executive Director of Business Development at INC Research from October 2011 to January 2016, where strategic leadership and account business plans were developed to align with corporate growth objectives.
This person is not in any teams
This person is not in any offices
APCER Life Sciences
APCER Life Sciences provides comprehensive drug safety/pharmacovigilance, medical information, medical writing, regulatory services, quality assurance and risk management programs to pharmaceutical and biotech companies globally. We bring medicinal / scientific expertise through our healthcare professionals & physicians and address full pharmacovigilance requirements for North America, UK & Europe markets. Our clients benefit from our vast experience in regulatory submissions across 100+ countries and consultative approach towards audit /inspection readiness. Our focus towards Patient safety and Risk profile management makes us the preferred choice for pharma companies who are looking for pre /post marketing compliance & reporting solutions. We have scalable operations across five global offices which house more than 750 employees: Princeton, NJ, USA; London, UK; Germany, Wan Chai, Hong Kong, New Delhi and Ahmedabad, India.